PYXS
Pyxis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
+9.12%Aug 13, 2026, 11:00 UTC
Pyxis Oncology reported financial results for the quarter ended June 30, 2026.
Source:Aug 13, 2026, 11:00 UTC
Pyxis Oncology completed a private placement financing for up to $114 million, raising approximately $50 million in upfront gross proceeds to support patient follow-up and extend its cash runway into the second quarter of 2027.
Source:Jul 2, 2026, 00:00 UTC
Pyxis Oncology entered into a securities purchase agreement for a private placement of 19,600,153 common shares at $2.551 per share and warrants, expecting $50 million in gross upfront proceeds.